Unravelling Ras signals in cardiovascular disease

被引:31
作者
Chien, KR [1 ]
Hoshijima, M [1 ]
机构
[1] Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA
关键词
D O I
10.1038/ncb0904-807
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The hyperplasia suppressor gene HSG, previously characterized for its function in mitochondrial fusion, has now been identified as a novel inhibitor of the Ras signalling pathway during smooth muscle cell proliferation. Because of the critical function of this process in atherosclerotic heart disease, these findings may have important clinical implications.
引用
收藏
页码:807 / 808
页数:2
相关论文
共 14 条
[1]   Dysregulation of HSG triggers vascular proliferative disorders [J].
Chen, KH ;
Guo, XM ;
Ma, DL ;
Guo, YH ;
Li, QA ;
Yang, DM ;
Li, PF ;
Qiu, XY ;
Wen, SJ ;
Xiao, RP ;
Tang, JA .
NATURE CELL BIOLOGY, 2004, 6 (09) :872-U8
[2]   Converging pathways and principles in heart development and disease: CV@CSH [J].
Chien, KR ;
Olson, EN .
CELL, 2002, 110 (02) :153-162
[3]   Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies [J].
Dzau, VJ ;
Braun-Dullaeus, RC ;
Sedding, DG .
NATURE MEDICINE, 2002, 8 (11) :1249-1256
[4]  
GEISER JR, 1998, MOL BIOL CELL, V9, P1741
[5]   Mixed signals in heart failure: cancer rules [J].
Hoshijima, M ;
Chien, KR .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) :849-855
[6]   Mechanisms of disease - Signaling pathways for cardiac hypertrophy and failure [J].
Hunter, JJ ;
Chien, KR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1276-1283
[7]   Timeline - RAS oncogenes: the first 30 years [J].
Malumbres, M ;
Barbacid, M .
NATURE REVIEWS CANCER, 2003, 3 (06) :459-465
[8]  
Malumbres M, 2003, NAT REV CANCER, V3, P708, DOI 10.1038/nrc1193
[9]   Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial [J].
Mann, MJ ;
Whittemore, AD ;
Donaldson, MC ;
Belkin, M ;
Conte, MS ;
Polak, JF ;
Orav, EJ ;
Ehsan, A ;
Dell'Acqua, G ;
Dzau, VJ .
LANCET, 1999, 354 (9189) :1493-1498
[10]   Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents - A serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) [J].
Mintz, GS ;
Tinana, A ;
Hong, MK ;
Lee, CW ;
Kim, JJ ;
Fearnot, NE ;
Park, SW ;
Park, SJ ;
Weissman, NJ .
CIRCULATION, 2003, 108 (11) :1295-1298